GlassScriptPhysician profile
Kara L Jefferies
NPI 1952407041
$1,102.24
in general payments reported to CMS, 2019-2025
17 companies · $83.72 in 2025
The $83.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $62.51 · 2021: $289 · 2022: $160 · 2023: $119 · 2024: $239 · 2025: $83.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.71 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $226.70 | 2019-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $177.66 | 2019-2025 | |
| Pfizer INC. | $168.70 | 2020-2025 | |
| Abbvie INC. | $106.70 | 2019-2021 | |
| Therapeuticsmd, INC. | $73.79 | 2019-2021 | |
| Exeltis, USA INC. | $62.42 | 2021-2023 | Slynd |
| Mayne Pharma Commercial LLC | $58.23 | 2022 | |
| Coopersurgical, INC. | $43.38 | 2019-2025 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $33.73 | 2021 | |
| Avion Pharmaceuticals | $28.82 | 2021 | |
| Evofem Biosciences, INC. | $25.98 | 2021-2022 | |
| Myovant Sciences INC. | $24.30 | 2022 | |
| Daiichi Sankyo INC. | $22.83 | 2021 | |
| Duchesnay USA Incorporated | $21.87 | 2019 | |
| Medtronic, INC. | $15.90 | 2024 | V-Loc 180 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $11.23 | 2025 | Ova1 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Jefferies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.